• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, November 22, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Pilot Trial Tests Imaging Versus Flow Ratio for Coronary Balloon Interventions

by
November 21, 2026
in Health
Reading Time: 3 mins read
0
Pilot Trial Tests Imaging Versus Flow Ratio for Coronary Balloon Interventions

Pilot Trial Tests Imaging Versus Flow Ratio for Coronary Balloon Interventions

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In a prospective pilot randomised trial evaluating procedural decision strategies for drug-coated balloon treatment in non-complex coronary lesions, researchers evaluated whether a quantitative flow ratio approach could match intravascular ultrasound combined with functional confirmation. The single-centre study investigated how distinct physiological and imaging guidance strategies perform during percutaneous coronary interventions, specifically assessing whether on-line computational flow assessment combined with virtual intervention planning provides adequate post-procedural functional outcomes compared with ultrasound guidance.

Investigators sought to determine procedural feasibility and generate effect size estimates required to power future large-scale clinical trials. The trial specifically enrolled patients presenting with non-complex coronary lesions to contrast a computational functional approach directly against an intravascular imaging methodology confirmed by functional measurement.

The study protocol randomised 78 patients representing 82 target vessels in an open-label, 1:1 allocation ratio between two interventional management pathways. Among the randomised cohort, four participants contributed two distinct vessels each to the final vessel pool. Forty-three vessels were allocated to the quantitative flow ratio pathway utilizing on-line computational analysis and virtual percutaneous intervention planning, while 39 vessels underwent intravascular ultrasound guidance accompanied by quantitative flow ratio confirmation.

Immediate post-procedural functional success served as the primary trial endpoint, established strictly as an offline post-PCI quantitative flow ratio of 0.90 or greater determined by an independent core laboratory. The primary statistical effect measure was calculated as the absolute risk difference with a 95 percent confidence interval derived through patient-level cluster bootstrap methods. Primary analytical cohorts incorporated all 78 randomised patients, with primary endpoint data successfully obtained across all 82 treated vessels.

Analysis of post-procedural hemodynamics revealed that functional success was achieved in 79.1 percent of vessels in the computational flow guided arm, corresponding to 34 out of 43 lesions. Within the intravascular ultrasound plus flow confirmation arm, 84.6 percent of vessels reached functional success, accounting for 33 of 39 lesions. This comparison yielded an absolute risk difference of minus 5.5 percentage points with a 95 percent confidence interval ranging from minus 21.3 to 11.7 percentage points, alongside a covariate-adjusted odds ratio of 0.58 with a 95 percent confidence interval spanning 0.18 to 1.85.

Unplanned stent implantation occurred in three vessels, representing 7.7 percent of the intravascular ultrasound plus confirmation arm, while none occurred in the computational flow cohort. These three events comprised two intraprocedural bailout stenting procedures and one early unplanned reintervention. Notably, two of the three stented vessels had previously met the threshold for post-procedural functional success before requiring scaffold placement. When evaluating a post-hoc composite endpoint of functional success without stent implantation, rates were 79.1 percent in the flow guided arm and 79.5 percent in the ultrasound guided arm, representing an absolute risk difference of minus 0.4 percentage points with a 95 percent confidence interval from minus 17.2 to 17.5 percentage points.

The authors concluded that both intraprocedural guidance strategies were feasible for delivering drug-coated balloon therapy in non-complex coronary lesions. However, because the observed confidence intervals were wide, clinically meaningful performance differences between the two modalities cannot be ruled out. The researchers noted that these initial feasibility and effect size estimates should guide the design of future confirmatory clinical trials powered specifically for hard clinical event endpoints.

Subject of Research: Comparison of QFR-guided versus IVUS-guided strategies for drug-coated balloon angioplasty in non-complex coronary lesions

Article Title: QFR-guided versus IVUS-guided with QFR confirmation for drug-coated balloon treatment of non-complex coronary lesions: a single-centre pilot randomised trial

Article References: Zhao, X., Zhou, Q., Jiang, Y., Ye, Y., & Luo, H. (2026). QFR-guided versus IVUS-guided with QFR confirmation for drug-coated balloon treatment of non-complex coronary lesions: a single-centre pilot randomised trial. BMC Cardiovascular Disorders. https://doi.org/10.1186/s12872-026-07055-2

Image Credits: AI Generated

DOI: 10.1186/s12872-026-07055-2

Keywords: drug-coated balloons, quantitative flow ratio, intravascular ultrasound, coronary artery disease, percutaneous coronary intervention, virtual PCI, functional success, bailout stenting, pilot randomised trial, coronary angiography, interventional cardiology, hemodynamic assessment, vessel dissection, clinical trial design, coronary lesions, cardiovascular medicine

News Source: Ophelia Keating. (November 21, 2026). Pilot Trial Tests Imaging Versus Flow Ratio for Coronary Balloon Interventions. Scienmag.

Tags: bailout stentingcardiovascular medicineClinical trial designcoronary angiographyCoronary artery diseasecoronary lesionsdrug-coated balloonsfunctional successhemodynamic assessmentinterventional cardiologyintravascular ultrasoundPercutaneous Coronary Interventionpilot randomised trialquantitative flow ratiovessel dissectionvirtual PCI
Share12Tweet7Share2ShareShareShare1

Related Posts

Japanese Neonatal Care Shows Higher Survival for Infants Under 24 Weeks

Japanese Neonatal Care Shows Higher Survival for Infants Under 24 Weeks

November 22, 2026
Single-Cell Sequencing Uncovers How STAP2 Drives Diabetic Retinal Vascular Dysfunction

Single-Cell Sequencing Uncovers How STAP2 Drives Diabetic Retinal Vascular Dysfunction

November 22, 2026

Heterozygous BRCA1 Mutations Disrupt Ovarian Blood Vessel Formation Before Cancer Develops

November 22, 2026

Portable Microfluidic Platform Quantifies Post-Transplant Viral Infections at Point of Care

November 22, 2026

POPULAR NEWS

  • Regional Climate Simulations Reveal Non-Uniform Future Shifts in Canadian Maximum Precipitation

    Regional Climate Simulations Reveal Non-Uniform Future Shifts in Canadian Maximum Precipitation

    29 shares
    Share 12 Tweet 7
  • Single-Cell Sequencing Uncovers How STAP2 Drives Diabetic Retinal Vascular Dysfunction

    29 shares
    Share 12 Tweet 7
  • Heterozygous BRCA1 Mutations Disrupt Ovarian Blood Vessel Formation Before Cancer Develops

    29 shares
    Share 12 Tweet 7
  • Portable Microfluidic Platform Quantifies Post-Transplant Viral Infections at Point of Care

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Satellite Greenness Links to City Nitrogen Dioxide Weaken Sharply Under Spatial Validation

Japanese Neonatal Care Shows Higher Survival for Infants Under 24 Weeks

Regional Climate Simulations Reveal Non-Uniform Future Shifts in Canadian Maximum Precipitation

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.